|
EP1679668B1
(en)
*
|
1996-09-04 |
2010-01-27 |
Intertrust Technologies Corp. |
Trusted infrastructure support systems, methods and techniques for secure electronic commerce, electronic transactions, commerce process control and automation, distributed computing, and rights management
|
|
US6184226B1
(en)
*
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
US6982260B1
(en)
|
1999-11-22 |
2006-01-03 |
Warner-Lambert Company |
Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
|
|
HRP20020547B1
(hr)
|
1999-12-24 |
2011-06-30 |
Aventis Pharma Limited |
Azaindoli
|
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
CA2422367C
(en)
|
2000-09-15 |
2010-05-18 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
AU2002222293A1
(en)
*
|
2000-12-19 |
2002-07-01 |
Smithkline Beecham P.L.C. |
Pyrazolo(3,4-c)pyridines as gsk-3 inhibitors
|
|
EP1345926B1
(en)
*
|
2000-12-21 |
2006-05-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
CN1307173C
(zh)
|
2000-12-21 |
2007-03-28 |
葛兰素集团有限公司 |
作为血管生成调节剂的嘧啶胺
|
|
US7276523B2
(en)
|
2001-03-30 |
2007-10-02 |
Smithkline Beecham Corporation |
Aminopyridine derivatives as estrogen receptor modulators
|
|
US6884804B2
(en)
|
2001-05-16 |
2005-04-26 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of Src and other protein kinases
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
EP2264014A1
(en)
|
2001-08-31 |
2010-12-22 |
Université Louis Pasteur |
Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
|
|
WO2003030909A1
(en)
*
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
CZ2004359A3
(cs)
|
2001-09-26 |
2004-09-15 |
Pharmacia Italia S.P.A. |
Aminoindazolové deriváty aktivní jako inhibitory kinázy, způsob jejich přípravy a farmaceutické prostředky obsahující tyto deriváty
|
|
TWI330183B
(cg-RX-API-DMAC7.html)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
JP2005516005A
(ja)
|
2001-12-07 |
2005-06-02 |
バーテクス ファーマスーティカルズ インコーポレイテッド |
Ｇｓｋ−３阻害剤として有用なピリミジンベースの化合物
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
ES2262899T3
(es)
|
2001-12-17 |
2006-12-01 |
Smithkline Beecham Corporation |
Derivados de pirazolopiridazina.
|
|
AU2002361846A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
US20030158195A1
(en)
*
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
WO2003062209A2
(en)
|
2002-01-17 |
2003-07-31 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
MXPA04007697A
(es)
*
|
2002-02-06 |
2004-11-10 |
Vertex Pharma |
Compuestos de heteroarilo utiles como inhibidores de gsk-3.
|
|
ATE433973T1
(de)
|
2002-03-15 |
2009-07-15 |
Vertex Pharma |
Azolylaminoazine als inhibitoren von proteinkinasen
|
|
ATE468336T1
(de)
*
|
2002-03-15 |
2010-06-15 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
|
WO2003077921A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azinylaminoazoles as inhibitors of protein kinases
|
|
EP1494645A2
(en)
*
|
2002-04-05 |
2005-01-12 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Method of treating mucus hypersecretion
|
|
ATE457728T1
(de)
|
2002-05-01 |
2010-03-15 |
Vertex Pharma |
Kristallstruktur des aurora-2 proteins und dessen bindungstaschen
|
|
ATE493987T1
(de)
|
2002-05-22 |
2011-01-15 |
Amgen Inc |
Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen
|
|
JPWO2003104230A1
(ja)
*
|
2002-06-07 |
2005-10-06 |
協和醗酵工業株式会社 |
二環性ピリミジン誘導体
|
|
US7465736B2
(en)
|
2002-06-14 |
2008-12-16 |
Laboratoires Serono S.A. |
Azole methylidene cyanide derivatives and their use as protein kinase modulators
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
WO2004000318A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
|
EP1534716B1
(en)
*
|
2002-07-17 |
2008-04-23 |
Pfizer Italia S.r.l. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
|
AU2003256783A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Scios, Inc. |
METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-Beta INHIBITORS
|
|
ES2445208T3
(es)
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
|
CN1319968C
(zh)
*
|
2002-08-02 |
2007-06-06 |
沃泰克斯药物股份有限公司 |
用作gsk－3的抑制剂的吡唑组合物
|
|
EP1739087A1
(en)
*
|
2002-08-02 |
2007-01-03 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
|
EP1532120B1
(en)
*
|
2002-08-13 |
2009-01-14 |
MERCK SHARP & DOHME LTD. |
Phenylpyridazine derivatives as ligands for gaba receptors
|
|
BR0313397A
(pt)
*
|
2002-08-14 |
2005-06-28 |
Vertex Pharmaceuticals Incorpo |
Inibidores de proteina cinase e usos destes
|
|
JP4648703B2
(ja)
|
2002-09-05 |
2011-03-09 |
アベンティス・ファーマ・ソシエテ・アノニム |
医薬としての新規なアミノインダゾール誘導体及びこれらを含む医薬組成物
|
|
FR2844267B1
(fr)
*
|
2002-09-05 |
2008-02-15 |
Aventis Pharma Sa |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
UA80295C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Pyrazolopyridines and using the same
|
|
US20040132730A1
(en)
*
|
2002-09-10 |
2004-07-08 |
Jonathan Axon |
Inhibitors of TGFbeta
|
|
WO2004041789A1
(en)
|
2002-11-01 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
JP2006508107A
(ja)
|
2002-11-05 |
2006-03-09 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｊａｋおよび他のプロテインキナーゼのインヒビターとして有用な化合物
|
|
WO2004048365A1
(en)
*
|
2002-11-21 |
2004-06-10 |
Chiron Corporation |
2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
|
|
CN1735607B
(zh)
*
|
2002-11-21 |
2010-06-09 |
诺华疫苗和诊断公司 |
2,4,6-三取代的嘧啶作为磷脂酰肌醇(pi)3-激酶抑制剂及其在治疗癌症中的应用
|
|
EP1571146A4
(en)
*
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
|
|
CA2507948A1
(fr)
|
2002-12-12 |
2004-07-29 |
Aventis Pharma S.A. |
Derives d'aminoindazoles et leur utilisation comme inhibiteurs de kinases
|
|
FR2848554A1
(fr)
*
|
2002-12-12 |
2004-06-18 |
Aventis Pharma Sa |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US20040156869A1
(en)
|
2002-12-13 |
2004-08-12 |
Neurogen Corporation |
2-substituted quinazolin-4-ylamine analogues
|
|
WO2004072029A2
(en)
*
|
2003-02-06 |
2004-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridazines useful as inhibitors of protein kinases
|
|
US7157455B2
(en)
*
|
2003-02-10 |
2007-01-02 |
Hoffmann-La Roche Inc. |
4-Aminopyrimidine-5-one derivatives
|
|
WO2004087056A2
(en)
*
|
2003-03-28 |
2004-10-14 |
Scios Inc. |
BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
|
|
US7763627B2
(en)
*
|
2003-04-09 |
2010-07-27 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
JP2006524254A
(ja)
*
|
2003-04-24 |
2006-10-26 |
メルク エンド カムパニー インコーポレーテッド |
Ａｋｔ活性の阻害剤
|
|
WO2004096808A1
(en)
*
|
2003-04-28 |
2004-11-11 |
De Novo Pharmaceuticals Limited |
Triazine compounds and their use
|
|
US20070032537A1
(en)
*
|
2003-06-13 |
2007-02-08 |
Arena Pharmaceuticals, Inc. |
5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases
|
|
BRPI0411514A
(pt)
*
|
2003-06-20 |
2006-08-01 |
Coley Pharm Gmbh |
antagonistas de receptor toll-like de molécula pequena
|
|
TW200510373A
(en)
|
2003-07-14 |
2005-03-16 |
Neurogen Corp |
Substituted quinolin-4-ylamine analogues
|
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
|
EP1651612B9
(en)
|
2003-07-22 |
2012-09-05 |
Astex Therapeutics Limited |
3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
GB0317127D0
(en)
*
|
2003-07-22 |
2003-08-27 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
PT1656372E
(pt)
|
2003-07-30 |
2013-06-27 |
Rigel Pharmaceuticals Inc |
Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina
|
|
RU2006106710A
(ru)
*
|
2003-08-05 |
2007-09-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Конденсированные пиримидиновые соединения в качестве ингибиторов потенциалозависимых ионных каналов
|
|
PE20050338A1
(es)
*
|
2003-08-06 |
2005-05-16 |
Vertex Pharma |
Compuestos de aminotriazoles como inhibidores de proteina quinasas
|
|
AU2004276341B2
(en)
*
|
2003-09-23 |
2011-04-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrrole derivatives as protein kinase inhibitors
|
|
GB0323137D0
(en)
|
2003-10-03 |
2003-11-05 |
Chang Lisa C W |
2,4,6- Trisubstituted pyrimidines and their different uses
|
|
KR20060123164A
(ko)
*
|
2003-10-17 |
2006-12-01 |
아스트라제네카 아베 |
암 치료에 사용하기 위한 4-(피라졸-3-일아미노)피리미딘유도체
|
|
US8455489B2
(en)
*
|
2003-11-10 |
2013-06-04 |
Exelixis, Inc. |
Substituted pyrimidine compositions and methods of use
|
|
TW200528106A
(en)
|
2003-11-10 |
2005-09-01 |
Synta Pharmaceuticals Corp |
Pyridine compounds
|
|
KR101260717B1
(ko)
|
2003-12-03 |
2013-05-09 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
튜불린 저해제
|
|
WO2005056547A2
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
|
WO2005056552A1
(en)
|
2003-12-09 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Naphthyridine derivatives and their use as modulators of muscarinic receptors
|
|
WO2005061519A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
GEP20084439B
(en)
|
2004-01-23 |
2008-07-25 |
Amgen Inc |
Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
|
|
AU2005207946A1
(en)
|
2004-01-23 |
2005-08-11 |
Amgen Inc. |
Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
|
|
WO2005077938A1
(en)
*
|
2004-02-11 |
2005-08-25 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
EP1809614B1
(en)
|
2004-04-08 |
2014-05-07 |
TargeGen, Inc. |
Benzotriazine inhibitors of kinases
|
|
CA2561718A1
(en)
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
WO2005105788A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Indole derivatives and use thereof as kinase inhibitors
|
|
US7793137B2
(en)
|
2004-10-07 |
2010-09-07 |
Cisco Technology, Inc. |
Redundant power and data in a wired data telecommunincations network
|
|
DE602005003951T4
(de)
|
2004-05-14 |
2012-10-11 |
Millennium Pharmaceuticals, Inc. |
Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
|
|
EP1598348A1
(en)
|
2004-05-18 |
2005-11-23 |
Aventis Pharma Deutschland GmbH |
Novel pyridazinone derivatives as inhibitors of CDK2
|
|
EP1604988A1
(en)
*
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
GB0415364D0
(en)
*
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
WO2006012624A2
(en)
*
|
2004-07-21 |
2006-02-02 |
The Regents Of The University Of California |
Mechanism-based crosslinkers
|
|
JP2008510734A
(ja)
*
|
2004-08-18 |
2008-04-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
JP5006194B2
(ja)
|
2004-08-19 |
2012-08-22 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
高沸点の空気および／または温度感受性有用生成物の混合物の精留方法
|
|
GB0419416D0
(en)
*
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
|
EP1789413A1
(en)
|
2004-09-13 |
2007-05-30 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
AU2005286592A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
|
AR050948A1
(es)
|
2004-09-24 |
2006-12-06 |
Hoffmann La Roche |
Derivados de ftalazinona; su obtencion y su utilizacion en la fabricacion de medicamentos para el tratamiento del cancer.
|
|
US7285569B2
(en)
|
2004-09-24 |
2007-10-23 |
Hoff Hoffmann-La Roche Inc. |
Tricycles, their manufacture and use as pharmaceutical agents
|
|
BRPI0516751A
(pt)
|
2004-09-30 |
2008-09-16 |
Tibotec Pharm Ltd |
pirimidinas bicìclicas que inibem hcv
|
|
TW200621251A
(en)
|
2004-10-12 |
2006-07-01 |
Neurogen Corp |
Substituted biaryl quinolin-4-ylamine analogues
|
|
JP2008516973A
(ja)
*
|
2004-10-15 |
2008-05-22 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
ATE523199T1
(de)
|
2004-11-02 |
2011-09-15 |
Univ Northwestern |
Pyridazinverbindungen und verfahren
|
|
CN101087766B
(zh)
|
2004-11-02 |
2011-09-07 |
西北大学 |
哒嗪化合物、组合物和方法
|
|
MX2007005857A
(es)
*
|
2004-11-17 |
2007-10-10 |
Mikana Therapeutics Inc |
Inhibidores de cinasa.
|
|
JP5095409B2
(ja)
|
2004-11-24 |
2012-12-12 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
スピロ２，４−ピリミジンジアミン化合物およびその使用
|
|
ES2450566T3
(es)
|
2004-11-30 |
2014-03-25 |
Amgen Inc. |
Análogos de quinazolina y quinolinas y su uso como medicamentos para tratar el cáncer
|
|
US20060128710A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
JP2008525422A
(ja)
*
|
2004-12-23 |
2008-07-17 |
ファイザー・プロダクツ・インク |
抗癌剤として有用な複素芳香族誘導体
|
|
EP1841760B1
(en)
*
|
2004-12-30 |
2011-08-10 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
AU2006206458B2
(en)
|
2005-01-19 |
2012-10-25 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
JP4804480B2
(ja)
*
|
2005-01-26 |
2011-11-02 |
シェーリング コーポレイション |
癌の処置のためのプロテインキナーゼインヒビターとしての、３−（インダゾール−５−イル）−（１，２，４）トリアジン誘導体、および関連する化合物
|
|
ES2555063T3
(es)
*
|
2005-02-04 |
2015-12-28 |
Astrazeneca Ab |
Derivados de pirazolilaminopiridina útiles como inhibidores de quinasas
|
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
PL1853588T3
(pl)
|
2005-02-16 |
2008-11-28 |
Astrazeneca Ab |
Związki chemiczne
|
|
US20080161278A1
(en)
*
|
2005-03-23 |
2008-07-03 |
Astrazeneca Ab |
2-Azetidinyl-4-(1H-Pyrazol-3-Ylamino) Pyrimidines as Inhibitors of Insulin-Like Growth Factor-1 Receptor Activity
|
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
ATE517897T1
(de)
|
2005-03-25 |
2011-08-15 |
Tibotec Pharm Ltd |
Heterobicyclische inhibitoren von hvc
|
|
BRPI0609965A2
(pt)
*
|
2005-04-05 |
2011-10-11 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, métodos para produzir um efeito ant-proliferativo em um animal de sangue quente, para tratar uma doença ou condição médica, para a prevenção ou tratamento de tumores, e para o tratamento de cáncer, e, processo para a preparação de um composto ou de um sal farmaceuticamente aceitável do mesmo
|
|
GB0507347D0
(en)
*
|
2005-04-12 |
2005-05-18 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2006233537A1
(en)
|
2005-04-14 |
2006-10-19 |
F. Hoffmann-La Roche Ag |
Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
JP5075624B2
(ja)
|
2005-04-28 |
2012-11-21 |
田辺三菱製薬株式会社 |
シアノピリジン誘導体及びその医薬としての用途
|
|
WO2006117212A2
(en)
|
2005-05-04 |
2006-11-09 |
Develogen Aktiengesellschaft |
Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
|
|
CA2606760C
(en)
*
|
2005-05-04 |
2014-12-23 |
Renovis, Inc. |
Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions
|
|
WO2006117560A1
(en)
*
|
2005-05-05 |
2006-11-09 |
Astrazeneca Ab |
Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer
|
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
|
NZ564317A
(en)
*
|
2005-05-16 |
2011-01-28 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
|
AU2006261607A1
(en)
|
2005-06-24 |
2006-12-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis C.
|
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
|
JP2009504771A
(ja)
*
|
2005-08-18 |
2009-02-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ピラジンキナーゼ阻害剤
|
|
WO2007023382A2
(en)
*
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP2258357A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
EP1934219A1
(en)
|
2005-09-16 |
2008-06-25 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
|
EP1928456B1
(en)
*
|
2005-09-30 |
2015-04-22 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
|
UA96427C2
(en)
*
|
2005-09-30 |
2011-11-10 |
Мийкана Терапьютикс, Инк. |
Substituted pyrazole compounds
|
|
ES2274712B1
(es)
|
2005-10-06 |
2008-03-01 |
Laboratorios Almirall S.A. |
Nuevos derivados imidazopiridina.
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
GB0520657D0
(en)
*
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
WO2007047978A2
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
BRPI0618011A2
(pt)
*
|
2005-10-28 |
2011-08-16 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente
|
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
MX391408B
(es)
|
2005-11-01 |
2025-03-21 |
Impact Biomedicines Inc |
Inhibidores de biaril meta-pirimidina de cinasas.
|
|
SG166827A1
(en)
*
|
2005-11-03 |
2010-12-29 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
|
ES2778846T3
(es)
|
2005-11-08 |
2020-08-12 |
Vertex Pharma |
Moduladores heterocíclicos de transportadores de casete de unión a ATP
|
|
US7713987B2
(en)
|
2005-12-06 |
2010-05-11 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2,4-diamines and their uses
|
|
US8546404B2
(en)
|
2005-12-13 |
2013-10-01 |
Merck Sharp & Dohme |
Compounds that are ERK inhibitors
|
|
US7572809B2
(en)
|
2005-12-19 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Isoquinoline aminopyrazole derivatives
|
|
EP1966152A2
(en)
*
|
2005-12-20 |
2008-09-10 |
Takeda Pharmaceutical Company Limited |
Glucokinase activators
|
|
WO2007084557A2
(en)
|
2006-01-17 |
2007-07-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of janus kinases
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
KR20080103996A
(ko)
|
2006-02-16 |
2008-11-28 |
쉐링 코포레이션 |
Ｅｒｋ 억제제로서 피롤리딘 유도체
|
|
EP1991212A1
(en)
*
|
2006-03-08 |
2008-11-19 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20100216734A1
(en)
*
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
PE20080145A1
(es)
|
2006-03-21 |
2008-02-11 |
Janssen Pharmaceutica Nv |
Tetrahidro-pirimidoazepinas como moduladores de trpv1
|
|
CN101460466B
(zh)
*
|
2006-04-11 |
2012-06-13 |
沃泰克斯药物股份有限公司 |
适用作蛋白激酶抑制剂的噻唑类、咪唑类和吡唑类
|
|
EP2015750A2
(en)
|
2006-04-28 |
2009-01-21 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
|
EP2021000A2
(en)
|
2006-05-09 |
2009-02-11 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
JP2009536667A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
５ｈｔ受容体介在性の神経新生
|
|
RS52307B
(sr)
*
|
2006-06-27 |
2012-12-31 |
Takeda Pharmaceutical Company Limited |
Kondenzovana ciklična jedinjenja
|
|
WO2008001070A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Astrazeneca Ab |
Pyrimidine derivatives useful in the treatment of cancer
|
|
AU2007269540B2
(en)
*
|
2006-07-05 |
2013-06-27 |
Exelixis, Inc. |
Methods of using IGF1R and Abl kinase modulators
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
CA2656618C
(en)
|
2006-07-06 |
2014-08-26 |
Array Biopharma Inc. |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
|
KR20090064418A
(ko)
*
|
2006-09-08 |
2009-06-18 |
브레인셀즈 인코퍼레이션 |
4-아실아미노피리딘 유도체 포함 조합물
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
AU2007299920A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
JP2010505961A
(ja)
*
|
2006-10-09 |
2010-02-25 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
US20100120717A1
(en)
|
2006-10-09 |
2010-05-13 |
Brown Jason W |
Kinase inhibitors
|
|
MX2009004140A
(es)
|
2006-10-21 |
2009-07-10 |
Abbott Gmbh & Co Kg |
Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa 3.
|
|
CA2668429A1
(en)
*
|
2006-11-02 |
2008-05-15 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
|
ES2347721T3
(es)
*
|
2006-12-19 |
2010-11-03 |
Vertex Pharmaceuticals, Inc. |
Aminopirimidinas utiles como inhibidores de proteina quinasas.
|
|
US8637531B2
(en)
|
2006-12-26 |
2014-01-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyridmidines useful for treating viral infections
|
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
US8143394B2
(en)
|
2006-12-26 |
2012-03-27 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
KR20090108124A
(ko)
|
2007-02-06 |
2009-10-14 |
노파르티스 아게 |
Ｐｉ 3-키나제 억제제 및 그의 사용 방법
|
|
CA2676920A1
(en)
*
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperidine derivatives
|
|
CA2676715A1
(en)
*
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
TW200901975A
(en)
|
2007-03-05 |
2009-01-16 |
Kyowa Hakko Kogyo Kk |
Pharmaceutical composition
|
|
WO2008112642A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
|
MX2009009592A
(es)
*
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopiridinas utiles como inhibidores de proteinas cinasas.
|
|
ES2374335T3
(es)
*
|
2007-03-09 |
2012-02-15 |
Vertex Pharmaceuticals Incorporated |
Aminopirimidinas útiles como inhibidores de proteína quinasas.
|
|
NZ580343A
(en)
|
2007-04-13 |
2012-03-30 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
|
EP2155742A1
(en)
*
|
2007-04-18 |
2010-02-24 |
AstraZeneca AB |
5-aminopyrazol-3-yl-3h-imidazo [4,5-b]pyridine derivatives and their use for the treatment of cancer
|
|
JP5572087B2
(ja)
*
|
2007-05-02 |
2014-08-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害として有用なアミノピリミジン
|
|
EP2152696B1
(en)
*
|
2007-05-02 |
2014-09-24 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
|
WO2008137619A2
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
|
UA99459C2
(en)
*
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
|
US20100204231A1
(en)
*
|
2007-05-04 |
2010-08-12 |
Astrazeneca Ab |
Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancer
|
|
CA2686838C
(en)
|
2007-05-09 |
2017-03-14 |
Vertex Pharmaceuticals Incorporated |
Modulators of cftr
|
|
JP2010528021A
(ja)
*
|
2007-05-24 |
2010-08-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼのインヒビターとして有用なチアゾールおよびピラゾール
|
|
EP2166849A4
(en)
*
|
2007-06-11 |
2010-09-15 |
Miikana Therapeutics Inc |
SUBSTITUTED PYRAZOL COMPOUNDS
|
|
WO2008156580A1
(en)
*
|
2007-06-13 |
2008-12-24 |
Merck & Co., Inc. |
Triazole derivatives for treating alzheimer's disease and related conditions
|
|
CN101687840A
(zh)
|
2007-06-25 |
2010-03-31 |
霍夫曼-拉罗奇有限公司 |
作为激酶抑制剂的苯并咪唑酰胺基衍生物
|
|
AR067413A1
(es)
|
2007-07-05 |
2009-10-07 |
Genentech Inc |
Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
KR101624361B1
(ko)
*
|
2007-07-05 |
2016-05-25 |
어레이 바이오파마 인크. |
Ａｋｔ 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
|
|
KR20100038108A
(ko)
|
2007-07-25 |
2010-04-12 |
브리스톨-마이어스 스큅 컴퍼니 |
트리아진 키나제 억제제
|
|
TW200906818A
(en)
*
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2009018415A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
|
US8404856B2
(en)
|
2007-11-20 |
2013-03-26 |
Merck Sharp & Dohme Corp. |
Non-nucleoside reverse transcriptase inhibitors
|
|
CN101910156B
(zh)
|
2007-12-07 |
2013-12-04 |
沃泰克斯药物股份有限公司 |
3-(6-(1-(2,2-二氟苯并[d][1,3]间二氧杂环戊烯-5-基)环丙烷甲酰氨基)-3-甲基吡啶-2-基)苯甲酸的固体形式
|
|
MX364936B
(es)
|
2007-12-07 |
2019-05-15 |
Vertex Pharma |
Procesos para producir acidos cicloalquilcarboxamido-piridin benzoicos.
|
|
JP2011032169A
(ja)
*
|
2007-12-11 |
2011-02-17 |
Genecare Research Institute Co Ltd |
４−アミノピリミジン誘導体および該化合物を含有する医薬組成物
|
|
PE20091102A1
(es)
|
2007-12-17 |
2009-07-25 |
Janssen Pharmaceutica Nv |
Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1
|
|
CN101970415A
(zh)
*
|
2008-01-09 |
2011-02-09 |
阵列生物制药公司 |
作为AKT蛋白激酶抑制剂的5H-环戊二烯并[d]嘧啶
|
|
EP2240483B8
(en)
|
2008-01-09 |
2013-04-03 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
US8716483B2
(en)
|
2008-02-21 |
2014-05-06 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
|
NZ703814A
(en)
|
2008-02-28 |
2016-06-24 |
Vertex Pharma |
Heteroaryl derivatives as cftr modulators
|
|
WO2009145814A2
(en)
*
|
2008-03-10 |
2009-12-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
|
CL2009000904A1
(es)
*
|
2008-04-21 |
2010-04-30 |
Shionogi & Co |
Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
|
|
US8158656B2
(en)
*
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
PT2300013T
(pt)
|
2008-05-21 |
2017-10-31 |
Ariad Pharma Inc |
Derivados de fósforo como inibidores de cinases
|
|
JP2011522870A
(ja)
*
|
2008-06-11 |
2011-08-04 |
アストラゼネカ アクチボラグ |
癌および骨髄増殖性障害の処置に有用な三環式２，４−ジアミノ−ｌ，３，５−トリアジン誘導体
|
|
BRPI0915720A2
(pt)
|
2008-06-12 |
2015-08-04 |
Janssen Pharmaceutica Nv |
Moduladores de diaminopiridina, pirimidina, e piridazina do receptor de histamina h4
|
|
CA2727103A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Merck Patent Gmbh |
Naphthyridinones as aurora kinase inhibitors
|
|
US8536187B2
(en)
|
2008-07-03 |
2013-09-17 |
Gilead Sciences, Inc. |
2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
RU2473549C2
(ru)
*
|
2008-07-31 |
2013-01-27 |
Дженентек, Инк. |
Пиримидиновые соединения, композиции и способы применения
|
|
US20110251172A1
(en)
*
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
|
KR20110050549A
(ko)
*
|
2008-09-03 |
2011-05-13 |
버텍스 파마슈티칼스 인코포레이티드 |
공-결정 및 이를 포함하는 제약 제제
|
|
CA2737388C
(en)
*
|
2008-09-15 |
2017-07-11 |
Peter Walter |
Methods and compositions for modulating ire1, src, and abl activity
|
|
RU2011116928A
(ru)
*
|
2008-09-30 |
2012-11-20 |
Астразенека Аб (Se) |
Гетероциклические ингибиторы jак киназы
|
|
CA2744343A1
(en)
*
|
2008-11-19 |
2010-05-27 |
Renovis, Inc. |
6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
|
|
KR101048448B1
(ko)
|
2008-11-21 |
2011-07-11 |
한국화학연구원 |
신규 피라졸로[4,3-ｂ]피리딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
HUE027478T2
(en)
|
2009-02-05 |
2016-09-28 |
Takeda Pharmaceuticals Co |
Pyridazinone Compounds
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
EP2401267B1
(en)
*
|
2009-02-27 |
2014-01-15 |
Ambit Biosciences Corporation |
Jak kinase modulating quinazoline derivatives and their use in methods
|
|
JP2012519732A
(ja)
*
|
2009-03-09 |
2012-08-30 |
サーフェイス ロジックス，インコーポレイティド |
Ｒｈｏキナーゼ阻害剤
|
|
CN102548558B
(zh)
*
|
2009-03-23 |
2014-04-30 |
Msdk.K.公司 |
具有Aurora A选择性抑制作用的氨基吡啶衍生物
|
|
JP2012521427A
(ja)
*
|
2009-03-24 |
2012-09-13 |
Ｍｓｄ株式会社 |
オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
|
|
US8367690B2
(en)
*
|
2009-03-24 |
2013-02-05 |
Vertex Pharmaceuticals Inc. |
Aminopyridine derivatives having aurora a selective inhibitory action
|
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
JP2012529511A
(ja)
*
|
2009-06-08 |
2012-11-22 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
|
JP5785940B2
(ja)
*
|
2009-06-09 |
2015-09-30 |
アブラクシス バイオサイエンス， エルエルシー |
トリアジン誘導体類及びそれらの治療応用
|
|
BRPI1011527A2
(pt)
*
|
2009-06-09 |
2016-07-26 |
California Capital Equity Llc |
derivados de triazina substituídos com ureidofenil e suas aplicações terapêuticas.
|
|
CN102480961A
(zh)
*
|
2009-06-24 |
2012-05-30 |
健泰科生物技术公司 |
与含氧杂环稠合的嘧啶化合物、组合物和使用方法
|
|
US8637525B2
(en)
|
2009-07-31 |
2014-01-28 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
TWI468402B
(zh)
*
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β－類澱粉生成之化合物
|
|
US20110053916A1
(en)
*
|
2009-08-14 |
2011-03-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine compounds as tuberculosis inhibitors
|
|
CN102020657A
(zh)
*
|
2009-09-11 |
2011-04-20 |
上海艾力斯医药科技有限公司 |
稠合杂芳基衍生物、制备方法及其应用
|
|
RU2607635C2
(ru)
*
|
2009-11-12 |
2017-01-10 |
Ф.Хоффманн-Ля Рош Аг |
N-9-замещенные пуриновые соединения, композиции и способы применения
|
|
MX2012005225A
(es)
|
2009-11-12 |
2012-07-25 |
Hoffmann La Roche |
Compuestos y composiciones de purina n-7 sustituida y pirazolopirimidina, y metodos de uso.
|
|
MX2012009378A
(es)
|
2010-02-11 |
2012-09-12 |
Univ Vanderbilt |
Compuestos de pirazolopiridina, pirazolopirazina, pirazolopirimidina, pirazolotiofeno y pirazolotiazol como potenciadores alostericos mglur4, composiciones y metodos para tratar disfunciones neurologicas.
|
|
AR081760A1
(es)
|
2010-04-07 |
2012-10-17 |
Vertex Pharma |
Una composicion farmaceutica para administracion oral que comprende acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoico, un metodo para producir la misma, una tableta y una forma unitaria de dosificacion oral que la comprende y el uso de la misma para la fabricacion de un medicamento
|
|
MX2012013274A
(es)
|
2010-05-21 |
2013-05-28 |
Chemilia Ab |
Novedosos derivados de la pirimidina.
|
|
US8354420B2
(en)
|
2010-06-04 |
2013-01-15 |
Genentech, Inc. |
Aminopyrimidine derivatives as LRRK2 inhibitors
|
|
US20110319409A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Cox Christopher D |
7-aza-quinazoline pde10 inhibitors
|
|
AU2011296024B2
(en)
|
2010-09-01 |
2015-05-28 |
Ambit Biosciences Corporation |
Quinazoline compounds and methods of use thereof
|
|
MX336726B
(es)
|
2010-09-27 |
2016-01-27 |
Abbott Gmbh & Co Kg |
Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3.
|
|
WO2012059932A1
(en)
|
2010-11-01 |
2012-05-10 |
Aurigene Discovery Technologies Limited |
2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
|
|
WO2012060847A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
KR101566091B1
(ko)
|
2010-11-10 |
2015-11-04 |
에프. 호프만-라 로슈 아게 |
Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체
|
|
AU2011343039B2
(en)
|
2010-12-14 |
2017-03-02 |
Electrophoretics Limited |
Casein kinase 1delta (CK1delta) inhibitors
|
|
JP2014500308A
(ja)
|
2010-12-21 |
2014-01-09 |
ノバルティス アーゲー |
Ｖｐｓ３４阻害剤としてのビヘテロアリール化合物
|
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
US9481670B2
(en)
*
|
2011-01-25 |
2016-11-01 |
Sphaera Pharma Pte. Ltd. |
Triazine compounds
|
|
JP5886411B2
(ja)
|
2011-03-24 |
2016-03-16 |
ノビガ・リサーチ・エービーＮｏｖｉｇａ Ｒｅｓｅａｒｃｈ ＡＢ |
新規のピリミジン誘導体
|
|
JP2014512354A
(ja)
|
2011-04-01 |
2014-05-22 |
ジェネンテック， インコーポレイテッド |
Ａｋｔ阻害剤化合物及びエルロチニブの組み合わせ、及び使用方法
|
|
ES2688809T3
(es)
|
2011-04-01 |
2018-11-07 |
Genentech, Inc. |
Combinaciones de compuestos inhibidores de AKT y MEK para tratar el cáncer
|
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8846656B2
(en)
|
2011-07-22 |
2014-09-30 |
Novartis Ag |
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
|
|
EP2748159A1
(en)
|
2011-08-25 |
2014-07-02 |
F.Hoffmann-La Roche Ag |
Serine/threonine pak1 inhibitors
|
|
ME03332B
(me)
|
2011-09-14 |
2019-10-20 |
Samumed Llc |
Indazol-3-karboksamidi i njihova upotreba kao inhibitora signalnog puta wnt/b-katenina
|
|
BR112014006840A2
(pt)
|
2011-09-22 |
2017-04-04 |
Pfizer |
derivados de pirrolopirimidina e purina
|
|
EP2771337B1
(en)
|
2011-09-27 |
2017-08-02 |
Novartis AG |
3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh
|
|
WO2013092940A1
(en)
|
2011-12-22 |
2013-06-27 |
F. Hoffmann-La Roche Ag |
2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors
|
|
UY34632A
(es)
|
2012-02-24 |
2013-05-31 |
Novartis Ag |
Compuestos de oxazolidin- 2- ona y usos de los mismos
|
|
JP6134376B2
(ja)
*
|
2012-03-16 |
2017-05-24 |
アクシキン ファーマシューティカルズ インコーポレーテッド |
３，５−ジアミノピラゾールキナーゼ阻害剤
|
|
WO2013140148A1
(en)
*
|
2012-03-19 |
2013-09-26 |
Imperial Innovations Limited |
Quinazoline compounds and their use in therapy
|
|
US20130303519A1
(en)
|
2012-03-20 |
2013-11-14 |
Millennium Pharmaceuticals, Inc. |
Methods of treating cancer using aurora kinase inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
IN2014KN02601A
(cg-RX-API-DMAC7.html)
|
2012-04-24 |
2015-05-08 |
Vertex Pharma |
|
|
BR112014027117B1
(pt)
*
|
2012-05-03 |
2022-09-06 |
Genentech, Inc |
Derivados de pirazol aminopirimidina como moduladores de lrrk2, seus usos, e composição
|
|
WO2013164321A1
(en)
*
|
2012-05-03 |
2013-11-07 |
F. Hoffmann-La Roche Ag |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators
|
|
BR112014032346A2
(pt)
|
2012-06-26 |
2017-06-27 |
Del Mar Pharmaceuticals |
métodos para tratamento de malignidades resistentes ao inibidor de tirosina-quinase em pacientes com polimorfismos genéticos ou desregulações de ahi1 mutações empregando dianidrogalactitol, diacetildianidrogalactitol, dibromodulcitol, ou análogos ou derivados destes
|
|
AU2013323360B2
(en)
|
2012-09-28 |
2017-09-07 |
Cancer Research Technology Limited |
Azaquinazoline inhibitors of atypical protein kinase C
|
|
JO3470B1
(ar)
|
2012-10-08 |
2020-07-05 |
Merck Sharp & Dohme |
مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
|
|
JP6243918B2
(ja)
*
|
2012-10-16 |
2017-12-06 |
トレロ ファーマシューティカルズ， インコーポレイテッド |
Ｐｋｍ２調節因子およびそれらの使用方法
|
|
US9296733B2
(en)
|
2012-11-12 |
2016-03-29 |
Novartis Ag |
Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
|
|
EP3181564B1
(en)
*
|
2012-11-20 |
2019-09-18 |
H. Hoffnabb-La Roche Ag |
Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
|
|
TWI623531B
(zh)
|
2012-11-21 |
2018-05-11 |
Ｐｔｃ治療公司 |
經取代反向嘧啶ｂｍｉ－１抑制劑
|
|
CN103012428A
(zh)
|
2013-01-08 |
2013-04-03 |
中国药科大学 |
4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
|
|
WO2014110086A2
(en)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Ｆｌａｐ調節劑
|
|
WO2014121055A2
(en)
*
|
2013-02-04 |
2014-08-07 |
Janssen Pharmaceutica Nv |
Flap modulators
|
|
EP2769722A1
(en)
*
|
2013-02-22 |
2014-08-27 |
Ruprecht-Karls-Universität Heidelberg |
Compounds for use in inhibiting HIV capsid assembly
|
|
JO3377B1
(ar)
*
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
|
ES2711839T3
(es)
|
2013-03-12 |
2019-05-07 |
Vertex Pharma |
Inhibidores de DNA-PK
|
|
AU2014229313B2
(en)
|
2013-03-14 |
2016-07-28 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
|
|
JP6360881B2
(ja)
|
2013-03-22 |
2018-07-18 |
ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
触媒的ｍｔｏｒｃ１／２阻害薬及びオーロラａキナーゼの選択的阻害薬の組合せ
|
|
CA2938626A1
(en)
|
2013-07-26 |
2015-01-29 |
John Rothman |
Compositions to improve the therapeutic benefit of bisantrene
|
|
JP6524094B2
(ja)
|
2013-08-30 |
2019-06-05 |
ピーティーシー セラピューティクス， インコーポレイテッド |
置換ピリミジンＢｍｉ−１阻害剤
|
|
WO2015028848A1
(en)
*
|
2013-09-02 |
2015-03-05 |
Piramal Enterprises Limited |
Bicyclic heterocyclic compounds as multi-kinase inhibitors
|
|
CA2924584A1
(en)
|
2013-10-03 |
2015-04-09 |
Kura Oncology, Inc. |
Inhibitors of erk and methods of use
|
|
JP6507157B2
(ja)
*
|
2013-10-07 |
2019-04-24 |
カドモン コーポレイション，リミティド ライアビリティ カンパニー |
Ｒｈｏキナーゼ阻害剤
|
|
MX361488B
(es)
|
2013-10-17 |
2018-12-07 |
Vertex Pharma |
Cocristales de (s)-n-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il ) amino)propan-2-il)quinolina-4-carboxamida y sus derivados deuterados como inhibidores de proteínas cinasa dependientes de adn (adn-pk).
|
|
RU2016122882A
(ru)
|
2013-11-12 |
2017-12-19 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения фармацевтических композиций для лечения опосредованных cftr заболеваний
|
|
US9975878B2
(en)
|
2013-11-21 |
2018-05-22 |
Ptc Therapeutics, Inc. |
Substituted triazine BMI-1 inhibitors
|
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
|
EP3071553A4
(en)
|
2013-11-21 |
2017-08-02 |
PTC Therapeutics, Inc. |
Substituted pyridine and pyrazine bmi-1 inhibitors
|
|
CN104672250B
(zh)
*
|
2013-11-29 |
2017-11-07 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
EP3089971B1
(en)
|
2014-01-01 |
2020-07-29 |
Medivation Technologies LLC |
Compounds and methods of use
|
|
WO2015112739A1
(en)
*
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
|
CN104926794B
(zh)
*
|
2014-03-17 |
2017-12-05 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
TWI675836B
(zh)
|
2014-03-25 |
2019-11-01 |
美商伊格尼塔公司 |
非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑
|
|
CA2945263A1
(en)
|
2014-04-09 |
2015-10-15 |
Christopher Rudd |
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
|
|
CN105367555B
(zh)
*
|
2014-08-07 |
2019-06-25 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
MX381732B
(es)
|
2014-11-18 |
2025-03-13 |
Vertex Pharma |
Proceso para efectuar la prueba de alto rendimiento de la cromatografia liquida de alta resolucion.
|
|
TWI704151B
(zh)
*
|
2014-12-22 |
2020-09-11 |
美商美國禮來大藥廠 |
Ｅｒｋ抑制劑
|
|
ES2700200T3
(es)
*
|
2014-12-22 |
2019-02-14 |
Lilly Co Eli |
Inhibidores de ERK
|
|
WO2016123627A1
(en)
|
2015-01-30 |
2016-08-04 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
|
|
EP3070084A1
(en)
*
|
2015-03-18 |
2016-09-21 |
Rottapharm Biotech S.r.l. |
New fyn kinase inhibitors
|
|
WO2016166604A1
(en)
|
2015-04-17 |
2016-10-20 |
Ludwig Institute For Cancer Research Ltd |
Plk4 inhibitors
|
|
AU2016270373A1
(en)
|
2015-06-05 |
2018-01-04 |
Vertex Pharmaceuticals Incorporated |
Triazoles for the treatment of demyelinating diseases
|
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017023986A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
CN108473491A
(zh)
|
2015-11-06 |
2018-08-31 |
萨穆梅德有限公司 |
2-(1h-吲唑-3-基)-3h-咪唑并[4,5-c]吡啶以及其抗炎用途
|
|
GB201604647D0
(en)
*
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
SI3464285T1
(sl)
|
2016-06-01 |
2023-02-28 |
Biosplice Therapeutics, Inc. |
Postopek za pripravo N-(5-(3-(7-(3-fluorofenil)-3H-imidazo(4,5-C)piridin-2-il)-1H-indazol-5- il)piridin-3-il)-3-metilbutanamida
|
|
AU2017335648B2
(en)
|
2016-09-27 |
2022-02-17 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
|
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
|
US10870630B2
(en)
|
2016-11-01 |
2020-12-22 |
Merck Sharp & Dohme Corp. |
Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
|
|
WO2018085865A1
(en)
|
2016-11-07 |
2018-05-11 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
|
IT201700047189A1
(it)
*
|
2017-05-02 |
2018-11-02 |
Fondazione St Italiano Tecnologia |
Composti e composizioni per il trattamento di cancro, disordini della retina e cardiomiopatie
|
|
AR112027A1
(es)
*
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
EP3421464B1
(en)
|
2017-06-30 |
2021-11-24 |
Beijing Tide Pharmaceutical Co., Ltd. |
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
|
|
CN110573501B
(zh)
|
2017-06-30 |
2023-09-29 |
北京泰德制药股份有限公司 |
Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
|
|
EP3647311B1
(en)
|
2017-06-30 |
2023-11-01 |
Beijing Tide Pharmaceutical Co., Ltd. |
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
|
|
CN109384774B
(zh)
*
|
2017-08-11 |
2023-02-17 |
中国科学院上海药物研究所 |
一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用
|
|
CA3074034A1
(en)
|
2017-10-27 |
2019-05-02 |
Theravance Biopharma R&D Ip, Llc |
Pyrimidine compound as jak kinase inhibitor
|
|
GB201801226D0
(en)
*
|
2018-01-25 |
2018-03-14 |
Redx Pharma Plc |
Modulators of Rho-associated protein kinase
|
|
WO2020005935A1
(en)
*
|
2018-06-25 |
2020-01-02 |
Kadmon Corporation, Llc |
Glucose uptake inhibitors
|
|
AU2019340402B2
(en)
|
2018-08-17 |
2025-04-03 |
Ptc Therapeutics, Inc. |
Method for treating pancreatic cancer
|
|
CN112739698A
(zh)
|
2018-08-24 |
2021-04-30 |
捷豹治疗有限公司 |
作为ahr调节剂的四氢嘧啶衍生物
|
|
KR102328682B1
(ko)
*
|
2018-08-27 |
2021-11-18 |
주식회사 대웅제약 |
신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
|
|
WO2020045941A1
(ko)
*
|
2018-08-27 |
2020-03-05 |
주식회사 대웅제약 |
신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
GEP20237519B
(en)
*
|
2018-12-27 |
2023-07-10 |
Servier Lab |
Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
|
|
US12286442B2
(en)
|
2019-01-03 |
2025-04-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Methods and materials for increasing transcription factor eb polypeptide levels
|
|
WO2020163812A1
(en)
|
2019-02-08 |
2020-08-13 |
Frequency Therapeutics, Inc. |
Valproic acid compounds and wnt agonists for treating ear disorders
|
|
US11384083B2
(en)
|
2019-02-15 |
2022-07-12 |
Incyte Corporation |
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
|
|
WO2020180959A1
(en)
|
2019-03-05 |
2020-09-10 |
Incyte Corporation |
Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
|
|
JP7547360B2
(ja)
|
2019-03-22 |
2024-09-09 |
スミトモ ファーマ オンコロジー， インコーポレイテッド |
Ｐｋｍ２モジュレーターを含む組成物およびそれを使用する処置の方法
|
|
US20220213119A1
(en)
|
2019-03-28 |
2022-07-07 |
Jiangsu Hengrui Medicine Ca, Lid. |
Thienoheterocyclic derivative, preparation method therefor and medical use thereof
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
WO2020200069A1
(zh)
|
2019-03-29 |
2020-10-08 |
江苏恒瑞医药股份有限公司 |
吡咯并杂环类衍生物、其制备方法及其在医药上的应用
|
|
CN109826608A
(zh)
*
|
2019-04-08 |
2019-05-31 |
中国科学院地质与地球物理研究所 |
一种分段压裂装置
|
|
US20230219956A1
(en)
*
|
2019-04-22 |
2023-07-13 |
Betta Pharmaceuticals Co.,Ltd |
Quinazoline compound and pharmaceutical application thereof
|
|
JP7470713B2
(ja)
|
2019-04-24 |
2024-04-18 |
セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー |
Ｊａｋキナーゼ阻害剤としてのエステルおよびカルボナートピリミジン化合物
|
|
CA3135388A1
(en)
|
2019-04-24 |
2020-10-29 |
Theravance Biopharma R&D Ip, Llc |
Pyrimidine jak inhibitors for the treatment of skin diseases
|
|
WO2020223469A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
US20220204512A1
(en)
|
2019-05-24 |
2022-06-30 |
Jiangsu Hengrui Medicine Co., Ltd. |
Substituted fused bicyclic derivative, preparation method therefor, and application thereof in medicines
|
|
EP3976584A1
(en)
*
|
2019-05-29 |
2022-04-06 |
IFM Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
|
PE20221010A1
(es)
|
2019-08-14 |
2022-06-15 |
Incyte Corp |
Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2
|
|
CN114302876A
(zh)
*
|
2019-09-06 |
2022-04-08 |
英夫拉索姆有限公司 |
Nlrp3抑制剂
|
|
CA3153456A1
(en)
*
|
2019-10-02 |
2021-04-08 |
Stefanie Fluckiger-Mangual |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer
|
|
WO2021072232A1
(en)
|
2019-10-11 |
2021-04-15 |
Incyte Corporation |
Bicyclic amines as cdk2 inhibitors
|
|
EP4090426B1
(en)
|
2020-01-13 |
2025-12-31 |
Verge Analytics, Inc. |
Substitutes for pyrazolos and pyrimidines and their uses
|
|
JP2023515128A
(ja)
*
|
2020-02-26 |
2023-04-12 |
ジャガー セラピューティクス ピーティーイーリミテッド |
Ａｈｒシグナル伝達の調節に有用なピリドピリミジン誘導体
|
|
CA3176957A1
(en)
*
|
2020-03-27 |
2021-09-30 |
Dong-A St Co., Ltd. |
Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulators
|
|
WO2021260111A1
(en)
|
2020-06-25 |
2021-12-30 |
Tolremo Therapeutics Ag |
Combination of a cbp/p300 bromodomain inhibitor and a kras inhibitor for the treatment of cancer
|
|
JP7686741B2
(ja)
*
|
2020-07-15 |
2025-06-02 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
Ａｌｋ５阻害剤としてのピリダジニルアミノ誘導体
|
|
WO2022032484A1
(zh)
*
|
2020-08-11 |
2022-02-17 |
北京诺诚健华医药科技有限公司 |
哒嗪-3-甲酰胺类化合物、其制备方法及其在医药学上的应用
|
|
CN114149410B
(zh)
*
|
2020-09-07 |
2025-02-25 |
四川科伦博泰生物医药股份有限公司 |
吡啶并环类化合物及其制备方法和用途
|
|
TW202221001A
(zh)
|
2020-09-29 |
2022-06-01 |
大陸商江蘇恒瑞醫藥股份有限公司 |
吡咯並雜環類衍生物的晶型及其製備方法
|
|
WO2022107919A1
(ko)
*
|
2020-11-19 |
2022-05-27 |
주식회사 보로노이 |
N을 포함하는 헤테로아릴 유도체 및 이를 유효성분으로 포함하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
KR20230160350A
(ko)
*
|
2021-03-24 |
2023-11-23 |
아토스 테라퓨틱스, 인크. |
키나제-관련 질환의 치료를 위한 소분자
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
CN117897384A
(zh)
|
2021-06-28 |
2024-04-16 |
缆图药品公司 |
Cdk2抑制剂
|
|
AR127108A1
(es)
|
2021-09-21 |
2023-12-20 |
Chiesi Farm Spa |
Derivados de amino piridazinilo como inhibidores de alk5
|
|
CN116023380B
(zh)
*
|
2021-10-26 |
2024-01-23 |
沈阳药科大学 |
一类吡唑并嘧啶衍生物及制备方法和应用
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
KR20240134173A
(ko)
|
2022-01-11 |
2024-09-06 |
키에시 파르마슈티시 엣스. 피. 에이. |
Alk5 억제제로서 피리다진일 아미노 유도체
|
|
WO2024206628A1
(en)
*
|
2023-03-30 |
2024-10-03 |
Nalo Therapeutics |
Modulators of myc family proto-oncogene protein
|